Lakefront Biotherapeutics NV SEC filings GLPGF
Lakefront Biotherapeutics NV has 545 filings in SEC EDGAR's recent list, going back to Nov 14, 2007. Its latest annual report, Form 20-F, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 4, 2026.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Oct 2, 2017 | — |
| CORRESP | Letter to the SEC | Sep 13, 2017 | — |
| UPLOAD | Letter from the SEC | Sep 5, 2017 | — |
| CORRESP | Letter to the SEC | Aug 16, 2017 | — |
| UPLOAD | Letter from the SEC | Aug 2, 2017 | — |
| CT ORDER | Filing | Jul 27, 2016 | — |
| CT ORDER | Filing | Feb 19, 2016 | — |
| CT ORDER | Filing | Jul 6, 2015 | — |
| EFFECT | Filing | May 13, 2015 | — |
| CERTNAS | Auto-generated paper document | May 13, 2015 | — |
| UPLOAD | Letter from the SEC | May 12, 2015 | — |
| 8-A12B | Filing | May 8, 2015 | — |
| CORRESP | Letter to the SEC | May 8, 2015 | — |
| CORRESP | Letter to the SEC | May 8, 2015 | — |
| EFFECT | Filing | Apr 30, 2015 | — |
| DRS/A | Filing | Mar 19, 2015 | — |
| UPLOAD | Letter from the SEC | Mar 9, 2015 | — |
| DRS/A | Filing | Mar 4, 2015 | — |
| DRS | Filing | Feb 6, 2015 | — |
| EFFECT | Filing | Mar 11, 2008 | — |
| SUPPL | Auto-generated paper document | Nov 14, 2007 | — |
| 12G3-2B | Auto-generated paper document | Nov 14, 2007 | — |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LKFT (Nasdaq), GLPGF (OTC)
- Incorporated in
- Belgium
- Headquarters
- 2800 Mechelen
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1421876
- Former names
- GALAPAGOS NV (until May 6, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.